Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva + Gemcitabine vs Gemcitabine in Advanced NSCLC
NCT00518011Phase 2Completed
- Sponsor
- Roche
- Start
- Aug 2007
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by Roche. Started Aug 2007; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00518011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00518011.